Cannabis, corona, and the latest morality developments in European trademark law
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › fagfællebedømt
Standard
Cannabis, corona, and the latest morality developments in European trademark law. / van der Donk, Berdien B E.
I: Journal of Intellectual Property Law & Practice, Bind 17, Nr. 3, 2022, s. 303-307.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Cannabis, corona, and the latest morality developments in European trademark law
AU - van der Donk, Berdien B E
PY - 2022
Y1 - 2022
N2 - This article provides an update on article 7 (1)(f) EUTMR, which covers the absolute ground of refusal for European trademarks contrary to public policy or principles of morality. The application of article 7 (1)(f) is strongly influenced by societal changes and therefore always subject to interpretational developments. In this article, the scope of article 7 (1)(f) is assessed in light of two recent developments: the emergence of the covid-19 pandemic, and the rise of cannabis use for therapeutic purposes. Both developments have sparked an increase in trademark applications and refusals. Firstly, a short overview of the application of article 7 (1)(f) is provided, followed by a thorough discussion of the European trademark refusals of the past two years (2019-2021) related to either cannabis or corona. It will show an inconsistency in the refusal of trademark on grounds of public policy and morality, mainly in relation to cannabis. It furthermore demonstrates the importance of the (social) context when assessing a potential moral controversy in a trademark, especially when the refusal is due to ‘suspected’ terminology, such as cannabis or corona.
AB - This article provides an update on article 7 (1)(f) EUTMR, which covers the absolute ground of refusal for European trademarks contrary to public policy or principles of morality. The application of article 7 (1)(f) is strongly influenced by societal changes and therefore always subject to interpretational developments. In this article, the scope of article 7 (1)(f) is assessed in light of two recent developments: the emergence of the covid-19 pandemic, and the rise of cannabis use for therapeutic purposes. Both developments have sparked an increase in trademark applications and refusals. Firstly, a short overview of the application of article 7 (1)(f) is provided, followed by a thorough discussion of the European trademark refusals of the past two years (2019-2021) related to either cannabis or corona. It will show an inconsistency in the refusal of trademark on grounds of public policy and morality, mainly in relation to cannabis. It furthermore demonstrates the importance of the (social) context when assessing a potential moral controversy in a trademark, especially when the refusal is due to ‘suspected’ terminology, such as cannabis or corona.
U2 - 10.1093/jiplp/jpac012
DO - 10.1093/jiplp/jpac012
M3 - Journal article
VL - 17
SP - 303
EP - 307
JO - Journal of Intellectual Property Law & Practice
JF - Journal of Intellectual Property Law & Practice
SN - 1747-1532
IS - 3
ER -
ID: 284421283